GeoVax Expands Rights Under NIH COVID-19 License To Include Mpox And Smallpox; Financial Terms Of The License Agreement Were Not Disclosed
GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that it has amended a previously executed Patent and Biological